SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia at AACR 2018.
Author: Cancer-News
Added: 05/24/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts